Variant report

Variant	nsv518337
Chromosome Location	chr7:3196333-3240101
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:523)
CpG islands
(count:854)
Chromatin interactive
region (count:20)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:523 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:3203948-3204296	HepG2	liver:	n/a	n/a
2	ARID3A	chr7:3234233-3234865	HepG2	liver:	n/a	n/a
3	ARID3A	chr7:3221006-3221355	HepG2	liver:	n/a	n/a
4	ATF2	chr7:3234272-3234806	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr7:3234177-3234810	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr7:3234182-3234735	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCL3	chr7:3234202-3234797	A549	lung:	n/a	n/a
8	BCL3	chr7:3220998-3221446	GM12878	blood:	n/a	n/a
9	BCL3	chr7:3221093-3221491	GM12878	blood:	n/a	n/a
10	BHLHE40	chr7:3216612-3216813	K562	blood:	n/a	n/a
11	CEBPB	chr7:3234396-3234625	HepG2	liver:	n/a	n/a
12	CEBPB	chr7:3221076-3221267	IMR90	lung:	n/a	n/a
13	CEBPB	chr7:3234322-3234665	A549	lung:	n/a	n/a
14	CEBPB	chr7:3234098-3234698	IMR90	lung:	n/a	n/a
15	CEBPB	chr7:3215918-3216112	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr7:3234205-3234712	HepG2	liver:	n/a	n/a
17	CEBPB	chr7:3220965-3221379	HepG2	liver:	n/a	n/a
18	CEBPB	chr7:3234293-3234711	H1-hESC	embryonic stem cell:	n/a	n/a
19	CEBPB	chr7:3234300-3234711	A549	lung:	n/a	n/a
20	CEBPB	chr7:3231891-3232043	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr7:3234374-3234541	K562	blood:	n/a	n/a
22	CHD2	chr7:3221032-3221442	HepG2	liver:	n/a	n/a
23	CHD2	chr7:3234357-3234596	HepG2	liver:	n/a	n/a
24	CTBP2	chr7:3234305-3234912	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr7:3202037-3202180	MCF-7	breast:	n/a	chr7:3202038-3202045
26	CTCF	chr7:3197260-3197410	HCPEpiC	choroid plexus:	n/a	n/a
27	CTCF	chr7:3202080-3202230	HCT-116	colon:	n/a	n/a
28	CTCF	chr7:3234322-3234483	MCF-7	breast:	n/a	n/a
29	CTCF	chr7:3202100-3202250	K562	blood:	n/a	n/a
30	CTCF	chr7:3202032-3202166	GM19240	blood:	n/a	chr7:3202038-3202045
31	CTCF	chr7:3202020-3202170	HBMEC	blood vessel:	n/a	chr7:3202038-3202045
32	CTCF	chr7:3202014-3202198	HUVEC	blood vessel:	n/a	chr7:3202038-3202045
33	CTCF	chr7:3202060-3202210	GM12870	blood:	n/a	n/a
34	CTCF	chr7:3201940-3202090	HEK293	kidney:	n/a	chr7:3202038-3202045
35	CTCF	chr7:3234360-3234510	HVMF	connective:	n/a	n/a
36	CTCF	chr7:3202000-3202150	GM12871	blood:	n/a	chr7:3202038-3202045
37	CTCF	chr7:3202060-3202210	HAc	cerebellar:	n/a	n/a
38	CTCF	chr7:3202020-3202170	Hela-S3	cervix:	n/a	chr7:3202038-3202045
39	CTCF	chr7:3202040-3202190	HMF	breast:	n/a	n/a
40	CTCF	chr7:3201964-3202252	H1-hESC	embryonic stem cell:	n/a	chr7:3202038-3202045
41	CTCF	chr7:3234360-3234510	AG09319	gingival:	n/a	n/a
42	CTCF	chr7:3202000-3202150	GM12872	blood:	n/a	chr7:3202038-3202045
43	CTCF	chr7:3234338-3234440	Kidney_OC	kidney:	n/a	n/a
44	CTCF	chr7:3234300-3234450	NHLF	lung:	n/a	n/a
45	CTCF	chr7:3202020-3202170	WERI-Rb-1	eye:	n/a	chr7:3202038-3202045
46	CTCF	chr7:3202040-3202190	GM12864	blood:	n/a	n/a
47	CTCF	chr7:3234320-3234470	HepG2	liver:	n/a	n/a
48	CTCF	chr7:3234320-3234470	HRPEpiC	eye:	n/a	n/a
49	CTCF	chr7:3234300-3234450	GM12873	blood:	n/a	n/a
50	CTCF	chr7:3202020-3202170	SK-N-SH_RA	brain:	n/a	chr7:3202038-3202045

(count:854 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:3234697-3234747	BJ	skin:	n/a
2	chr7:3208793-3208843	GM12892	blood:	n/a
3	chr7:3221373-3221423	SKMC	muscle:	n/a
4	chr7:3215543-3215593	ProgFib	skin:	n/a
5	chr7:3208793-3208843	NH-A	brain:	n/a
6	chr7:3227277-3227327	CMK	blood:	n/a
7	chr7:3227332-3227382	ProgFib	skin:	n/a
8	chr7:3227262-3227312	HEEpiC	esophagus:	n/a
9	chr7:3221373-3221423	Caco-2	colon:	n/a
10	chr7:3227262-3227312	NH-A	brain:	n/a
11	chr7:3207719-3207769	AG10803	skin:	n/a
12	chr7:3208493-3208543	SK-N-MC	brain:	n/a
13	chr7:3215543-3215593	HCM	heart:	n/a
14	chr7:3227277-3227327	ovcar-3	ovarian:	n/a
15	chr7:3227277-3227327	SAEC	small airway:	n/a
16	chr7:3234697-3234747	HNPCEpiC	eye:	n/a
17	chr7:3227277-3227327	HCM	heart:	n/a
18	chr7:3227262-3227312	PFSK-1	brain:	n/a
19	chr7:3215287-3215337	AG09309	skin:	n/a
20	chr7:3227277-3227327	HMEC	breast:	n/a
21	chr7:3208793-3208843	NB4	blood:	n/a
22	chr7:3227332-3227382	HMEC	breast:	n/a
23	chr7:3214289-3214339	Caco-2	colon:	n/a
24	chr7:3207719-3207769	GM12891	blood:	n/a
25	chr7:3227262-3227312	Hela-S3	cervix:	n/a
26	chr7:3215287-3215337	NH-A	brain:	n/a
27	chr7:3227332-3227382	NHDF-neo	bronchial:	n/a
28	chr7:3214400-3214450	HCM	heart:	n/a
29	chr7:3234697-3234747	SKMC	muscle:	n/a
30	chr7:3234697-3234747	HEK293	kidney:	embryo
31	chr7:3214400-3214450	GM19239	blood:	n/a
32	chr7:3227332-3227382	HPAEpiC	pulmonary alveolar:	n/a
33	chr7:3234697-3234747	HCF	heart:	n/a
34	chr7:3234697-3234747	GM06990	blood:	n/a
35	chr7:3227332-3227382	SAEC	small airway:	n/a
36	chr7:3221373-3221423	U87	brain:	n/a
37	chr7:3215543-3215593	HCPEpiC	choroid plexus:	n/a
38	chr7:3221150-3221200	HCPEpiC	choroid plexus:	n/a
39	chr7:3227277-3227327	MCF10A-Er-Src	breast:	n/a
40	chr7:3215287-3215337	AG04449	skin:	fetal
41	chr7:3214289-3214339	GM12892	blood:	n/a
42	chr7:3215287-3215337	SK-N-SH_RA	brain:	n/a
43	chr7:3227277-3227327	Caco-2	colon:	n/a
44	chr7:3234697-3234747	HMEC	breast:	n/a
45	chr7:3221373-3221423	LNCaP	prostate:	n/a
46	chr7:3221228-3221278	SK-N-MC	brain:	n/a
47	chr7:3227332-3227382	A549	lung:	n/a
48	chr7:3214289-3214339	GM12878	blood:	n/a
49	chr7:3215287-3215337	SAEC	small airway:	n/a
50	chr7:3214400-3214450	Hepatocyte	liver:	n/a

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:2926249..2926927-chr7:3240062..3240775,2	MCF-7	breast:
2	chr7:3201417..3202351-chr7:3240242..3240878,3	MCF-7	breast:
3	chr7:3104998..3105685-chr7:3239854..3240733,2	MCF-7	breast:
4	chr7:2912750..2915143-chr7:3228683..3231010,3	MCF-7	breast:
5	chr7:2921568..2923869-chr7:3228214..3231115,2	MCF-7	breast:
6	chr7:3128837..3129871-chr7:3239803..3240577,4	MCF-7	breast:
7	chr7:3227729..3230209-chr7:3232264..3234725,2	MCF-7	breast:
8	chr7:3210617..3212945-chr7:3214732..3216839,2	K562	blood:
9	chr7:3198032..3200716-chr7:3210631..3213455,2	MCF-7	breast:
10	chr7:3205607..3207977-chr7:3220687..3223407,2	K562	blood:
11	chr7:3227729..3230209-chr7:3232264..3234725,2	MCF-7	breast:
12	chr7:3210617..3212945-chr7:3214732..3216839,2	K562	blood:
13	chr7:3205607..3207977-chr7:3220687..3223407,2	K562	blood:
14	chr7:2915975..2917721-chr7:3231286..3232804,2	MCF-7	breast:
15	chr7:2913057..2915172-chr7:3198284..3201204,2	MCF-7	breast:
16	chr7:2926533..2927268-chr7:3239915..3240463,3	MCF-7	breast:
17	chr7:3210592..3212478-chr7:3220599..3222530,2	K562	blood:
18	chr7:2914055..2915867-chr7:3204506..3206043,2	MCF-7	breast:
19	chr7:3210553..3212945-chr7:3214110..3216839,3	K562	blood:
20	chr7:3210592..3212478-chr7:3220599..3222530,2	K562	blood:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC091801.1.1-1	chr7:3197771-3197888	XLOC_006339
2	lnc-AC091801.1.1-1	chr7:3214230-3214287	XLOC_006339
3	lnc-CARD11-4	chr7:3204171-3204221	NONHSAT118845
4	lnc-CARD11-4	chr7:3202784-3203088	NONHSAT118845
5	lnc-AC091801.1.1-2	chr7:3234354-3234428	XLOC_006340
6	lnc-CARD11-4	chr7:3204353-3204414	NONHSAT118845
7	lnc-AC091801.1.1-1	chr7:3205664-3205764	XLOC_006339
8	lnc-AC091801.1.1-1	chr7:3205664-3205764	NONHSAT118844
9	lnc-AC091801.1.1-1	chr7:3214230-3214287	NONHSAT118844
10	lnc-AC091801.1.1-2	chr7:3233737-3234256	XLOC_006340
11	lnc-AC091801.1.1-1	chr7:3197771-3197975	XLOC_006339

No data

Variant related genes	Relation type
ENSG00000217455	TF binding region
ENSG00000231892	TF binding region
ENSG00000217455	CpG island
ENSG00000231892	CpG island
ENSG00000217455	chromatin interactions

Extended variants
information (count: 2486 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:2486 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1074119	chr7:3196333-3196334	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs2396953	chr7:3196369-3196370	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs578027225	chr7:3196387-3196388	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs533955963	chr7:3196424-3196425	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs1074118	chr7:3196435-3196436	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs573248020	chr7:3196449-3196450	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs552716694	chr7:3196466-3196467	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs531541052	chr7:3196475-3196476	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs150719884	chr7:3196488-3196489	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs183209724	chr7:3196546-3196547	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs536267706	chr7:3196593-3196594	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs544233275	chr7:3196596-3196597	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs186501327	chr7:3196610-3196611	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs75913433	chr7:3196611-3196612	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs540417140	chr7:3196647-3196648	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs9791708	chr7:3196656-3196657	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs11766372	chr7:3196703-3196704	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs559237569	chr7:3196730-3196731	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs190496617	chr7:3196763-3196764	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs555695043	chr7:3196777-3196778	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs62440820	chr7:3196783-3196784	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs34786210	chr7:3196788-3196789	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs182975601	chr7:3196806-3196807	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs577540277	chr7:3196823-3196824	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs370623726	chr7:3196828-3196829	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs149875723	chr7:3196854-3196855	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs187609570	chr7:3196871-3196872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs375114692	chr7:3196880-3196881	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs534124348	chr7:3196903-3196904	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs553969066	chr7:3196912-3196913	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs567458571	chr7:3196931-3196932	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs78773242	chr7:3196940-3196941	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs116753120	chr7:3196951-3196952	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs555845996	chr7:3196993-3196994	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs145140934	chr7:3197012-3197013	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs140221577	chr7:3197068-3197069	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs367976248	chr7:3197094-3197095	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs557769943	chr7:3197117-3197118	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs73291016	chr7:3197118-3197119	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs192906027	chr7:3197122-3197123	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs560450254	chr7:3197134-3197135	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs117960777	chr7:3197151-3197152	Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs28489713	chr7:3197203-3197204	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs149105711	chr7:3197242-3197243	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs531483809	chr7:3197246-3197247	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs562081468	chr7:3197271-3197272	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs144445789	chr7:3197289-3197290	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs571272660	chr7:3197300-3197301	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs527537344	chr7:3197326-3197327	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs183044803	chr7:3197345-3197346	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Chordoma	21602918	CNVD
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Nasopharyngeal cancer	20548289	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
Spondylocostal dysostosis	21085971	CNVD
Mental retardation	17901693	CNVD
Heart disease	21282601	CNVD
Glioblastoma multiforme	22286061	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	20164920	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:355 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:3178400-3204600	Weak transcription	Right Atrium	heart
2	chr7:3191600-3197200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr7:3192200-3197200	Weak transcription	Primary B cells from cord blood	blood
4	chr7:3192600-3196800	Weak transcription	Primary B cells from peripheral blood	blood
5	chr7:3193600-3197000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
6	chr7:3196800-3197600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr7:3196800-3197600	Enhancers	Primary B cells from peripheral blood	blood
8	chr7:3197000-3197200	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
9	chr7:3197000-3197400	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr7:3197000-3197600	Enhancers	Esophagus	oesophagus
11	chr7:3197000-3197800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr7:3197000-3197800	Enhancers	H1 Cell Line	embryonic stem cell
13	chr7:3197000-3197800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr7:3197000-3198200	Enhancers	iPS-15b Cell Line	embryonic stem cell
15	chr7:3197200-3197400	Enhancers	Primary T helper cells fromperipheralblood	blood
16	chr7:3197200-3197600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr7:3197200-3197600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
18	chr7:3197200-3197600	Bivalent Enhancer	Fetal Muscle Leg	muscle
19	chr7:3197200-3197800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr7:3197200-3197800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
21	chr7:3197200-3197800	Enhancers	Primary B cells from cord blood	blood
22	chr7:3197200-3197800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr7:3197200-3197800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr7:3197200-3197800	Enhancers	NH-A	brain
25	chr7:3197400-3198800	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr7:3197600-3197800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr7:3197600-3197800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr7:3197600-3197800	Flanking Active TSS	Esophagus	oesophagus
29	chr7:3197600-3197800	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
30	chr7:3197600-3197800	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
31	chr7:3197600-3198000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr7:3197600-3198000	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr7:3197600-3198000	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
34	chr7:3197600-3198000	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
35	chr7:3197600-3198000	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
36	chr7:3197600-3198200	Enhancers	ES-I3 Cell Line	embryonic stem cell
37	chr7:3197600-3198600	Bivalent Enhancer	Adipose Nuclei	Adipose
38	chr7:3197800-3198000	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
39	chr7:3197800-3199200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr7:3197800-3207000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr7:3198000-3198200	Active TSS	Fetal Muscle Leg	muscle
42	chr7:3198000-3198400	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
43	chr7:3198200-3199000	Enhancers	Fetal Muscle Leg	muscle
44	chr7:3198400-3198600	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
45	chr7:3198800-3199200	Enhancers	Fetal Kidney	kidney
46	chr7:3198800-3201400	Enhancers	Pancreas	Pancrea
47	chr7:3199200-3200600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr7:3201000-3201200	Enhancers	Gastric	stomach
49	chr7:3201200-3203000	Weak transcription	Gastric	stomach
50	chr7:3201400-3202800	Weak transcription	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links